Yahoo Web Search

  1. No in-person doctor visits, no trips to the pharmacy. Try BlueChew today! BlueChew is a telemedicine service delivering chewable Sildenafil, Tadalafil & Vardenafil.

Search results

  1. Jun 28, 2024 · Roughly a month after announcing that it would offer GLP-1 injectable weight loss drugs comparable to the popular drugs Ozempic and Monjaro to customers, Hims & Hers Health shares are taking a ...

  2. Jun 27, 2024 · Shares of Hims & Hers, the telehealth company, are under pressure as scrutiny of its weight loss business intensifies. On Wednesday, Heard on the Street argued that Hims’s 150% stock market g

  3. Jun 28, 2024 · The market for GLP-1 is expected to grow at a CAGR of 19.2% through 2029 and may reach a market size of $109 billion. Hims & Hers Health (HIMS) already boasts a Zacks Rank #1 (Strong Buy) rating ...

  4. Jun 27, 2024 · Hims & Hers Health ( NYSE: HIMS) is down ~6% following a report that is raising eyebrows both on how easy it is to get a prescription for GLP-1 weight loss drugs and the supplier of its compounded ...

  5. Jun 19, 2024 · Hims & Hers Health, Inc. (HIMS) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in...

  6. 1 day ago · Hims & Hers Health, Inc.’s HIMS investors are enjoying some short-term gains from the stock of late. Shares of the San Francisco, CA-based health and wellness platform have rallied 37.7% in the ...

  7. Jun 26, 2024 · Hims & Hers Health offers telehealth services focusing on wellness and specialized care. Investors can buy shares through a brokerage account to invest directly. Research company financials...